FOSUN PHARMA
60019622.620.57% ( -0.13 )
FOSUN PHARMA (600196)
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical business in Mainland China and internationally. It operates through five segments:...
- Open
- 22.62
- High
- 22.89
- Low
- 22.52
- Prev. Close
- 22.75
- Volume
- 137.16K
- Turnover
- 310.71M
- Avg Price
- 22.65
- Bid/Ask Ratio
- --
- Amplitude
- 1.63%
- 52wk High
- 32.71
- Volume Ratio
- 0.35
- Turnover Ratio
- 0.65%
FOSUN PHARMA Analyst Rating
View MoreForecast & Rating
Jul 24, 2026Price forecast
¥34.4652.36%
Forecast & RatingBuy
7analysts
- Strong buy42.86%
- Buy28.57%
- Hold28.57%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · Jul 16 at 06:33 AM
Virax Biolabs signs Fosun Diagnostics supply deal for ImmuneSelect in six Southeast Asian markets
- StockTitan · Jul 15 at 10:30 PM
Virax Biolabs' CEO James Foster Provides Shareholder Update Following Fiscal 2026 Annual Report and Fosun Diagnostics Commercial Supply Agreement | VRAX Stock News
- PUBT · Jul 15 at 05:14 AM
Fosun Pharma Shenzhen wins China approval to start Phase I trial of FXR0906 for hypertriglyceridemia
- Tip Ranks · Jul 13 at 07:27 PM
Shanghai Fosun Pharmaceutical (Group) Co (SFOSF) Gets a Hold from HSBC
- rttnews · Jul 9 at 09:55 PM
Top Biotech Gainers: VRAX Jumps 100% After Fosun Deal, FBRX Soars On Vitiligo Data, TRAX On Watch
- StockTitan · Jul 8 at 10:30 PM
Virax Biolabs Signs Multi-Country Commercial Supply Agreement with Fosun Diagnostics | VRAX Stock News
